Upcoming Events October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to October 29, 2020 from 11:00 AM to 12:30 PM EDT Virtual TSX Life Sciences Investor Day Go to Past Events October 1, 2020 at 12:30 PM EDT Virtual Gravitas Healthcare Investor Day Go to September 30, 2020 at 10:00 AM EDT Medicenna Annual and Special Meeting Go to September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to June 18, 2020 at 1:40 PM EDT Raymond James Human Healthcare Innovation Conference Go to June 9 - June 12, 2020 Spring Virtual Investor Summit (Virtual) Go to Pagination Current page 1 Page 2 Page 3 Next page next › Last page last »
October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to
October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to
September 22, 2020 at 2:30 PM EDT Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (virtual) Go to
September 16, 2020 at 10:30 AM EDT H.C. Wainwright 22nd Annual Global Investment Conference 2020 (virtual) Go to
